MedPath

The Effectiveness of Wet Cupping on Persistent Non-specific Low Back Pain

Not Applicable
Completed
Conditions
Low Back Pain
Interventions
Device: Wet Cupping
Registration Number
NCT00925951
Lead Sponsor
Korea Institute of Oriental Medicine
Brief Summary

The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Waiting Control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Patients who have had non-specific low back pains at least 12 weeks now.
Exclusion Criteria
  • Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).

  • Patients who are inappropriate to the wet cupping treatment.

    • AIDS, Active Hepatitis, Tuberculosis, Syphilis
    • Patients who regularly take anticoagulants, antiplatelet drugs
    • Anemia, thrombocytopenia
    • Hemorrhagic disease like hemophilia
    • Diabetes
    • Severe cardiovascular disease
    • Kidney diseases (renal failure, chronic renal disease)
  • Patients who have experiences of wet cupping treatment during last 3 months.

  • Patients who have had treatment for low back pain during last 2 weeks.

  • Patients who are in pregnancy or have plan to conception.

  • Patients who have vertebra surgery or have plan of surgery.

  • Patients who are inappropriate to join this trial judged by the radiologists or specialists.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Wet CuppingWet Cupping-
Wet CuppingAcetaminophen-
Waiting ControlAcetaminophenThey can't use any other specific treatment except exercises and behavior modification (we'll offer a brochure which includes exercise method and directions about behavior modifications).
Primary Outcome Measures
NameTimeMethod
Numeric Rating Scale (NRS) for painstudy group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
Secondary Outcome Measures
NameTimeMethod
Medication Quantification Scale (MQS)study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
Present Pain Intensity Scale of the McGill Pain Questionaire (PPI)study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
General Assessment of Doctors and Subjectsstudy group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
Safety measurementstudy group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation
Oswestry Disability Questionnaire (ODQ)study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation

Trial Locations

Locations (1)

Korea Institue of Oriental Medicine (KIOM), Doonsan Oriental Hospital of Daejeon University

🇰🇷

Daejeon, Chungchong, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath